By Charles S. Wilcox, Ph.D/ November, 2017                                  Since the approval of Namenda in 2003, there has not been any new and novel medication approved for the treatment of mild-to-moderate, or moderate-to-severe Alzheimer’s disease. During these subsequent fourteen years, there has